Key points are not available for this paper at this time.
In Reply We appreciate the comments from Cheng and Hsu regarding our study1 on the clinical effectiveness of newborn screening (NBS) for spinal muscular atrophy (SMA). Their observations bring valuable perspectives that merit further discussion.
Schwartz et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: